Can GLP-1 Super Bowl Ads Reduce Stigma Around Weight Loss Drugs?
Share on PinterestNew GLP-1 ads, like telehealth provider Ro’s new campaign featuring tennis icon Serena Williams, aim to…
FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report
FDA Commissioner Marty Makary released a statement on X stating that the agency is expected to begin moving…
Hobart GP struck off for prescribing addictive drugs to vulnerable patients
A Hobart GP has been banned from practising medicine for at least two years after inappropriately prescribing addictive…
4 Natural Tinnitus Remedies Recommended by an Ear Doctor
Millions of Americans are dealing with tinnitus, phantom sounds that can cause very real distress. The rest of…
AI, fake me a prescription | India News
NEW DELHI: Artificial Intelligence is making it easier for people to procure restricted drugs, from antibiotics to addictive…
Controversial drug ivermectin could be sold over the counter
Since the pandemic began, Florida lawmakers and health officials have become fascinated with ivermectin for more than its…
Medicare Drug Price Negotiations: Selected Drugs for 2028
Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15…
Hims & Hers launches Wegovy knockoff pill; Novo Nordisk vows to sue
WASHINGTON — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the…
Ozempic and Wegovy could damage your eyesight, regulator warns
Taking Ozempic could cause sudden blindness in one eye, health officials have warned. The UK’s Medicines and Healthcare…
Clear Labels Act Would Require Manufacturing Locations on Prescription Drug Labels — ProPublica
Senators introduced legislation on Thursday that would require prescription drug labels to identify where the medication was made,…
Switzerland moves towards recognising of foreign osteopath diplomas
Movement in the recognition of foreign osteopathic diplomas Keystone-SDA The Swiss Federal Court has ruled in favour of…
MHRA updates guidance for semaglutide prescribers and patients
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (5 February 2026) updated product information for healthcare…